The Democratic Republic of Congo is facing a rapidly worsening Ebola outbreak after more than 300 deaths were recorded in a single week, one of the highest weekly tolls reported since the outbreak began. Government figures showed 5,514 cases and 2,642 deaths as of Saturday, highlighting the growing pressure on health workers.
The outbreak is being driven by the Bundibugyo strain of Ebola, a rare variant for which there is currently no approved vaccine or specific treatment. Nearly half of confirmed patients have died, while some hard-to-reach areas have reported significantly higher fatality rates.
The situation is particularly serious in Ituri province, considered the current epicenter. Health teams are struggling with poor roads, insecurity, population movements, misinformation and shortages of resources, making it difficult to identify infected people and trace their contacts.
Can the outbreak still be contained?
Yes, health authorities believe it can be controlled through rapid detection, isolation, treatment, contact tracing and vaccination efforts, although the current speed of transmission presents an exceptional challenge.
Congo recently received more than 16,000 doses of the Ervebo vaccine, which was previously used against another Ebola strain. Researchers are also studying whether it could provide some protection against Bundibugyo.
